Early Recognition & Management of Heart Failure in the Elderly
|
|
- Neal Marsh
- 5 years ago
- Views:
Transcription
1 Early Recognition & Management of Heart Failure in the Elderly ALMDA Winter 2015 Mid Winter Conference Gregory Payne MD, PhD Division of Cardiovascular Disease University of Alabama at Birmingham School of Medicine 1
2 Disclosures No Disclosures 2
3 78 year old man Presented to local ER with complaints of shortness of breath at rest and worsening dyspnea on exertion. History: Hypertension Chronic Kidney Disease Coronary Artery Disease s/p remote bypass surgery He currently lives alone and and states that he tries to stay compliant with all of his medications, but admits it is difficult He is hospitalized for heart failure exacerbation with echocardiogram that notes ejection fraction of 30% (he declines further invasive intervention). 3
4 78 year old man He is hospitalized for one week with successful diuresis and appropriate adjustments to his medications. He is discharged home, but. Re admitted within 2 weeks for heart failure exacerbation It is noted during this visit that he is deconditioned with significant cognitive impairment He ultimately is discharged to a nursing home for long term care. 4
5 An unprecedented epidemic National Vital Statistics System and the U.S. Census Bureau 5
6 An unprecedented epidemic Lifetime risk of heart failure (HF) is estimated to 20% for Americans over the 40 years of age While the incidence of new diagnosis remains flat (~650,000 annually) the prevalence continues to increase Incidence increases with age: 20 per 1000 individuals aged 65 to 69 years of age >80 per 1000 individuals aged 85 years of age Number of Americans with HF is expected to significantly worsen in the near future Konstam, MA. Circulation. 2012; 125:
7 An unprecedented epidemic Lifetime risk of heart failure is estimated to 20% for Americans over the 40 years of age While the incidence of new diagnosis remains flat (~650,000 annually) the prevalence continues to increase Incidence increases with age: 20 per 1000 individuals aged 65 to 69 years of age >80 per 1000 individuals aged 85 years of age Number of Americans with heart failure is expected to significantly worsen in the near future Konstam, MA. Circulation. 2012; 125:
8 Hospitalization & Heart Failure HF is the primary diagnosis in>1 million hospitalizations annually Patients hospitalized for HF are at high risk for all cause rehospitalization Of the $30 billion spent annually, >50% is spent in hospitalizations 1 month readmission rate of 25% 2013 ACCF/AHA Heart Failure Guidelines 8
9 Hospitalization & Heart Failure HF is significantly associated with functional impairment and poor quality of life (QOL) Lack of improvement of QOL (post discharge) is a powerful predictor of rehospitalization and mortality 2013 ACCF/AHA Heart Failure Guidelines 9
10 Heart Failure and Hospitalization Discharge to Post Acute or Long term Care facility Alabama 2005 Alabama 2009 National Vital Statistics System and the U.S. Census Bureau 10
11 Heart Failure and Hospitalization Early clinical deterioration is a common phenomenon among older patients with CHF after discharge S. Stewart, JD Horowitz / The European Journal of Heart Failure / 4 (2002)
12 The challenge ahead 12
13 Recognition & Management of Heart Failure in the Elderly Multidisciplinary Approach Identify High Risk Patients Optimal Medical Therapy Clinical Assessment Pathophysiology 13
14 ETIOLOGIES OF HEART FAILURE 14
15 Etiology of Heart Failure Complex Clinical Diagnosis Results from any structural or functional impairment of ventricular filling or ejection of blood Cardinal manifestations: Dyspnea fatigue exercise intolerance fluid retention congestive symptoms (orthopnea, cough, abdominal discomfort) 15
16 Etiology of Heart Failure Reduced Ejection Fraction (HFrEF) Left ventricular ejection fraction (LVEF) <40% Most studied group Goal directed therapy was designed for this patient population Randomized controlled trials (RCTs) Preserved Ejection Fraction (HFpEF) LVEF of 40%, Diastolic heart failure Very little evidence to support correct management No proven therapy Estimated 40 50% of clinical heart failure 16
17 Influence of EF on Survival in Patients with Heart Failure Vasan RS et al. J Am Coll Cardiol. 1999;33:
18 Heart Failure Etiology Ischemic Cardiomyopathy Chronic ischemia Sequela of Acute Coronary Syndrome Most prevalent within the aging population Non Ischemic Cardiomyopathy Very diverse list of causes Increasingly recognized within the aging population Valvular Heart Disease and Associated Cardiomyopathies Diseases of aging Aortic Stenosis Mitral Regurgitation 18
19 Prognosis depends on Etiology 1230 Patients referred for unexplained heart failure symptoms Felker GM. NEJM 2000;342:
20 Ischemic Cardiomyopathy 20
21 Non Ischemic Cardiomyopathies Non Ischemic Cardiomyopathy Endocrine Disorders Drug Induced HTN Arrhythmia Infiltrative Diabetes Thyroid Alcohol Drugs Chemo Afib Pacing Amyloidosis Sarcoidosis Also including inflammatory, malignant, infectious, etc. Large group of heterogeneous myocardial disorders Typically characterized by ventricular dilation and depressed contractility 21
22 Hypertensive Heart Failure Approximately 40% prevalence among elderly patients Sequelae: Accelerated coronary artery disease Left ventricular hypertrophy Diastolic Dysfunction and Heart failure (HFpEF) Left ventricular systolic dysfunction (HFrEF) Dilated Cardiomyopathy Chinnakali et al. Hypertension in the Elderly. N Am J Med Sci. Nov
23 Cardiac Amyloidosis Many variations of amyloidosis: Primary (AL amyloidosis) plasma cell dyscrasia leading to overproduction of Immunoglobulin light chains Secondary (AA amyloidosis) Deposition of fragments of serum amyloid A protein, an acute phase reactant Associated with chronic inflammatory disorders (eg RA). Senile systemic and Heritable amyloidosis Transthyretin (TTR) deposits Significant Cardiac involvement, but much slower time course than AL Later age at time of symptom development 23
24 Cardiac Amyloidosis Deposition of insoluble proteins as fibrils in the heart, resulting in HF Clinical manifestations: Nephropathy Neuropathy Organomegaly Purpura Apple green birefringence on biopsy Cardiac amyloid is increasingly recognized for causing HF in the elderly 24
25 Valvular Cardiomyopathy Aortic Stenosis Mitral Regurgitation Volume overload and heart failure 25
26 Aortic Stenosis Primarily degenerative valve disease in the elderly Typical presentation: Heart Failure (orthopnea, dyspnea) Angina Syncope Systolic Murmur on exam Valvular obstruction leads to cardiomyopathy and sudden death 26
27 2/3/2015 Aortic Stenosis 27
28 CLINICAL ASSESSMENT 28
29 Clinical Assessment Symptom Burden Functional / Medical Baseline Review & Management of Medications and Therapy Review of Laboratories & Diagnostic Studies Assessment of physical and social barriers (and support) Assessment of psychological status 29
30 Clinical Assessment: Symptoms & Exam Symptoms Baseline symptoms Dyspnea on exertion Orthpnea Peripheral Edema Physical Exam Volume status: Cardiac Auscultation (+S3) Jugular Venous Pressure Pulmonary edema Abdominal distention or ascites Hepatosplenomegaly Vital Signs Clues of decompensation Tachycardia Tachypneia Hypothermia Physical Exam Cognition Functional capacity 30
31 Estimation of Jugular Venous Pressure 31
32 Clinical Assessment Congestion Warm & Dry Warm & Wet Body Perfusion Optimal Hemodynamics: Focus on Disease progression and avoiding decompensation Cold & Dry Limited further options for therapy Diuresis Continuation of standard therapy Cold & Wet Diuresis and redesign of medical therapy 32
33 Clinical Assessment NYHA Functional Classification Class I: No limitation of physical activity. Ordinary physical activity w/o fatigue, palpitation, or dyspnea. Class II: Slight limitation of physical activity. Comfortable at rest, but symptoms w/ ordinary physical activity Class III: Marked limitation of physical activity. Comfortable at rest, but less than ordinary activity causes fatigue, palpitation, or dyspnea. Class IV: Unable to carry out any physical activity without discomfort. Symptoms include cardiac insufficiency at rest. If any physical activity is undertaken, discomfort is increased. J Cardiac Failure 1999; 5:
34 Clinical Assessment Goal Directed Medical Therapy (GDMT) Pharmacologic Therapy Primary therapy to delay disease progression Cardiac Rehabilitation Structured Exercise Nutritional Support Continued patient and family guidance Invasive therapies Implantable Cardiac Defibrillator (ICD) Cardiac Resynchronization Therapy (CRT) 34
35 GDMT: Pharmacologic Therapy J Am Coll Cardiol. 2013;62(16): doi: /j.jacc
36 GDMT: Pharmacologic Therapy J Am Coll Cardiol. 2013;62(16): doi: /j.jacc
37 GDMT: Pharmacologic Therapy Inappropriate Medications NSAIDs Calcium antagonists (Verapamil, diltiazem) TCAs Corticosteroids Class I antiarrhythmic drugs (flecainide) 37
38 GDMT: Cardiac Rehabilitation Several studies document clinical improvement Increased exercise capacity Improved Quality of Life Hospitalization and mortality HF Action Trial showed modest reductions with sponsored exercise HF ACTION RCT. JAMA April,
39 GDMT: Cardiac Rehabilitation Cumulative incidence of death by number of cardiac rehabilitation sessions attended Increased physical activity trends towards improved outcomes Kwan G, and Balady G J Circulation. 2012;125:e369 e373 39
40 GDMT: Cardiac Resynchronization Therapy Grines CL, Circulation 1989;79: Xiao HB, Br Heart J 1991;66: Søgaard P, JACC 2002;40: Interventricular Intraventricular Atrioventricular LV Dyssynchrony Reduced diastolic filling time Weakened contractility Worsened global function Increased symptom burden 40
41 GDMT: Cardiac Resynchronization Therapy 41
42 GDMT: Cardiac Resynchronization Therapy Improved Hemodynamics Increased CO Reduced LV filling pressures Reduced sympathetic activity Increased systolic function The only proven therapy to significantly improve Quality of Life Available with or without defibrillator therapy 42
43 GDMT: Objective Studies Daily Weights (superior to ins and outs) Accurate input & outputs Measurement of BNP (or pro BNP) Most helpful as a comparison to when the patient was euvolemic Routine labs Basic Metabolic Panels (GFR and electrolytes) 43
44 HIGH RISK PATIENTS 44
45 Identifying High Risk Patients The Seattle Heart Failure Score Robust tool to predict the 1, 2 and 5 year survival of heart failure patients: Age Gender NYHA Class Weight Ejection Fraction Blood pressure Medical Therapy (including ICD and CRT) Lab Data Predicts anticipated changes in survival with adjustments to medical therapy Levy W C et al. Circulation. 2006;113:
46 The Seattle Heart Failure Model Levy W C et al. Circulation. 2006;113:
47 Identifying High Risk Patients Among patients 65 years old, the following were risk factors for all cause re admission: Krumholz et al. American Heart Journal. Vol 139, #1, Part 1 47
48 Identifying High Risk Patients Among patients 65 years old, the following were risk factors for all cause re admission: Systematic Reviews Duration of hospitalization Functional disability Other comorbid conditions Importantly, age and sex alone were not indicative of risk Physiologic vs. chronologic age Almost every patient requiring Post Acute or Long Term Care is therefore high risk L. Garcia Perez et al. Q J Med 2011; 104:
49 MULTIDISCIPLINARY APPROACH 49
50 Multidisciplinary Approach Diagnosis and treatment strategies of heart failure are complex Significant co morbidities Alter the delivery, safety and efficacy of established therapies Nursing staff, social work, case management, general practitioners, geriatricians, cardiologists all need to cooperate 50
51 Multidisciplinary Approach Comprehensive discharge planning has long been known to decrease all cause readmission rates for heart failure Ideally initiated within the first hours Within nursing homes, no generalizable proven strategies to date Naylor M et. al. Comprehensive discharge planning for the hospitalized elderly: A randomized clinical trial. Ann Intern Med
52 Strategic Approach Continue Goal directed therapy to the fullest extent With appropriate monitoring (i.e. BMP) Maintain Euvolemia Accurate daily weights Input and Outputs (if possible) Avoid intravenous fluids (especially continuous) Maintain physical activity / Maximize mobility Adequate pain control Adequate nutrition Adequate bowel and bladder function Foster care support from family and friends Special focus to those at highest risk 52
53 Strategic Approach: DEFEAT HF D Diagnosis E Etiology F Fluid volume status E Ejection A fraction T Therapy H identify High Risk F Fine tune based on comorbidities Ahmed Ali et al. J Am Med Dir Assoc July; 9(6):
54 Summary Heart failure is a very common, disabling and costly disease Poor quality of life associated with a general poor prognosis Many of the highest risk patients require long term care facilities Heart failure management in long term care facilities is a unique challenge, that deserves unique approach. Early identification of these high risk patients may decrease rates of re admission, worsening morbidity and mortality 54
55 THANK YOU 55
56 56
57 Cardiac Amyloidosis Surface electrocardiogram demonstrating atrial fibrillation with low-voltage in the limb leads. Two-dimensional (2D) echocardiographic image (parasternal long-axis view) from a patient with AL cardiac amyloidosis showing normal biventricular dimensions, granular "speckling" ventricular wall appearance, concentric left ventricular wall thickening, and thickened mitral valve leaflets suggesting infiltration 57
Heart Failure. Cardiac Anatomy. Functions of the Heart. Cardiac Cycle/Hemodynamics. Determinants of Cardiac Output. Cardiac Output
Cardiac Anatomy Heart Failure Professor Qing ZHANG Department of Cardiology, West China Hospital www.blaufuss.org Cardiac Cycle/Hemodynamics Functions of the Heart Essential functions of the heart to cover
More informationHFpEF. April 26, 2018
HFpEF April 26, 2018 (J Am Coll Cardiol 2017;70:2476 86) HFpEF 50% or more (40-71%) of patients with CHF have preserved LV systolic function. HFpEF is an increasingly frequent hospital discharge. Outcomes
More informationDiagnosis & Management of Heart Failure. Abena A. Osei-Wusu, M.D. Medical Fiesta
Diagnosis & Management of Heart Failure Abena A. Osei-Wusu, M.D. Medical Fiesta Learning Objectives: 1) Become familiar with pathogenesis of congestive heart failure. 2) Discuss clinical manifestations
More informationHeart Failure Overview. Dr Chris K Y Wong
Heart Failure Overview Dr Chris K Y Wong Heart Failure: A Growing, Global Health Issue Heart Failure 23 Million Afflicted Global Impact Worldwide ~23 million peopleworldwide afflicted with CHF 1 Exceeds
More informationHeart Failure Dr ahmed almutairi Assistant professor internal medicin dept
Heart Failure Dr ahmed almutairi Assistant professor internal medicin dept (MBBS)(SBMD) Introduction Epidemiology Pathophysiology diastolic/systolic Risk factors Signs and symptoms Classification of HF
More informationKeynote Address II Managing Acute Heart Failure: What Can We Do to Improve Outcomes?
Keynote Address II Managing Acute Heart Failure: What Can We Do to Improve Outcomes? 24 th Annual San Diego Heart Failure Symposium June 1-2, 2018 La Jolla, CA Barry Greenberg, MD Distinguished Professor
More informationAssessment and Diagnosis of Heart Failure
Assessment and Diagnosis of Heart Failure Heart failure (HF) is a complex clinical syndrome resulting from any structural or functional impairment of ventricular filling or ejection of blood and is characterized
More informationImproving Transition of Care in Congestive Heart Failure. Mark J. Gloth, DO, MBA. Vice President, Chief Medical Officer HCR ManorCare
Improving Transition of Care in Congestive Heart Failure Mark J. Gloth, DO, MBA. Vice President, Chief Medical Officer HCR ManorCare Heart Failure Fastest growing clinical cardiac disease in the United
More informationTopic Page: congestive heart failure
Topic Page: congestive heart failure Definition: congestive heart f ailure from Merriam-Webster's Collegiate(R) Dictionary (1930) : heart failure in which the heart is unable to maintain an adequate circulation
More informationTherapeutic Targets and Interventions
Therapeutic Targets and Interventions Ali Valika, MD, FACC Advanced Heart Failure and Pulmonary Hypertension Advocate Medical Group Midwest Heart Foundation Disclosures: 1. Novartis: Speaker Honorarium
More informationHeart Failure. Dr. William Vosik. January, 2012
Heart Failure Dr. William Vosik January, 2012 Questions for clinicians to ask Is this heart failure? What is the underlying cause? What are the associated disease processes? Which evidence-based treatment
More informationNew CHF Patient in my Office: What Should I Do?
New CHF Patient in my Office: What Should I Do? Joseph Mishkin MD FACC Advanced Heart Failure, Transplantation and Mechanical Circulatory Support No disclosures Disclosures Clinical Presentation 38 year
More informationPathophysiology: Heart Failure
Pathophysiology: Heart Failure Mat Maurer, MD Irving Assistant Professor of Medicine Outline Definitions and Classifications Epidemiology Muscle and Chamber Function Pathophysiology Heart Failure: Definitions
More informationCLINICAL PRACTICE GUIDELINE
CLINICAL PRACTICE GUIDELINE Procedure: Congestive Heart Failure Guideline Review Cycle: Biennial Reviewed By: Amish Purohit, MD, MHA, CPE, FACHE Review Date: November 2014 Committee Approval Date: 11/12/2014
More informationIs it HF secondary to rheumatic heart disease???
Is it HF secondary to rheumatic heart disease??? Is mitral regurg. Is complication of CHF??? Cardiomyopathy Definition The term cardiomyopathy is purely descriptive, meaning disease of the heart muscle
More informationΜαρία Μπόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό
Μαρία Μπόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό Diastolic HF DD: Diastolic Dysfunction DHF: Diastolic HF HFpEF: HF with preserved EF DD Pathophysiologic condition: impaired relaxation, LV compliance, LV filling
More informationCongestive Heart Failure: Outpatient Management
The Chattanooga Heart Institute Cardiovascular Symposium Congestive Heart Failure: Outpatient Management E. Philip Lehman MD, MPP Disclosure No financial disclosures. Objectives Evidence-based therapy
More information2016 Update to Heart Failure Clinical Practice Guidelines
2016 Update to Heart Failure Clinical Practice Guidelines Mitchell T. Saltzberg, MD, FACC, FAHA, FHFSA Medical Director of Advanced Heart Failure Froedtert & Medical College of Wisconsin Stages, Phenotypes
More informationOutline. Pathophysiology: Heart Failure. Heart Failure. Heart Failure: Definitions. Etiologies. Etiologies
Outline Pathophysiology: Mat Maurer, MD Irving Assistant Professor of Medicine Definitions and Classifications Epidemiology Muscle and Chamber Function Pathophysiology : Definitions An inability of the
More informationThe Failing Heart in Primary Care
The Failing Heart in Primary Care Hamid Ikram How fares the Heart Failure Epidemic? 4357 patients, 57% women, mean age 74 years HFSA 2010 Practice Guideline (3.1) Heart Failure Prevention A careful and
More informationProtocol Identifier Subject Identifier Visit Description. [Y] Yes [N] No. [Y] Yes [N] N. If Yes, admission date and time: Day Month Year
PAST MEDICAL HISTORY Has the subject had a prior episode of heart failure? o Does the subject have a prior history of exposure to cardiotoxins, such as anthracyclines? URGENT HEART FAILURE VISIT Did heart
More informationObjectives. Systolic Heart Failure: Definitions. Heart Failure: Historical Perspective 2/7/2009
Objectives Diastolic Heart Failure and Indications for Echocardiography in the Asian Population Damon M. Kwan, MD UCSF Asian Heart & Vascular Symposium 02.07.09 Define diastolic heart failure and differentiate
More informationCharles Spencer MD, FRCP Consultant Cardiologist Mid Staffs NHSFT
Charles Spencer MD, FRCP Consultant Cardiologist Mid Staffs NHSFT Key Messages Heart Failure is Common Heart failure is complex Heart Failure is a major issue for the NHS Heart Failure has a worse prognosis
More informationHeart Failure Overview. Dr Chris K Y Wong
Heart Failure Overview Dr Chris K Y Wong Heart Failure: A Growing, Global Health Issue Heart Failure 23 Million Afflicted Global Impact Worldwide ~23 million peopleworldwide afflicted with CHF 1 Exceeds
More informationDialysis-Dependent Cardiomyopathy Patients Demonstrate Poor Survival Despite Reverse Remodeling With Cardiac Resynchronization Therapy
Dialysis-Dependent Cardiomyopathy Patients Demonstrate Poor Survival Despite Reverse Remodeling With Cardiac Resynchronization Therapy Evan Adelstein, MD, FHRS John Gorcsan III, MD Samir Saba, MD, FHRS
More informationHEART FAILURE IN WOMEN. Marian Limacher, MD Division of Cardiovascular Medicine University of Florida
HEART FAILURE IN WOMEN Marian Limacher, MD Division of Cardiovascular Medicine University of Florida Outline Epidemiology Clinical Overview Why HF is such a challenge State of the Field Heart Failure Adjudication
More informationSusan P. D Anna MSN, APRN BC February 14, 2019
Is there Equal Opportunity in Heart Failure?? Susan P. D Anna MSN, APRN BC February 14, 2019 Disclosures: I have no financial disclosures. I am not an expert on this topic, but see a lot of women with
More informationManagement Strategies for Advanced Heart Failure
Management Strategies for Advanced Heart Failure Mary Norine Walsh, MD, FACC Medical Director, HF and Cardiac Transplantation St Vincent Heart Indianapolis, IN USA President American College of Cardiology
More informationI have no disclosures. Disclosures
I have no disclosures Disclosures What is Heart Failure? Heart Failure (HF) A complex clinical syndrome where patients present with symptoms (i.e. dyspnea, fatigue, fluid retention) that result from any
More informationInnovation therapy in Heart Failure
Innovation therapy in Heart Failure P. Laothavorn September 2015 Topics of discussion Basic Knowledge about heart failure Standard therapy New emerging therapy References: standard Therapy in Heart Failure
More informationPresenter: Steven Brust, HCS-D, HCS-H Product Manager, Home Health Coding Center
Presenter: Steven Brust, HCS-D, HCS-H Product Manager, Home Health Coding Center Pinpoint & properly assign the appropriate heart failure codes Left- vs. Right-sided Left ventricular failure (LVF) may
More informationCopyright 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Normal Cardiac Anatomy
Mosby,, an affiliate of Elsevier Normal Cardiac Anatomy Impaired cardiac pumping Results in vasoconstriction & fluid retention Characterized by ventricular dysfunction, reduced exercise tolerance, diminished
More informationThe right heart: the Cinderella of heart failure
The right heart: the Cinderella of heart failure Piotr Ponikowski, MD, PhD, FESC Medical University, Centre for Heart Disease Clinical Military Hospital Wroclaw, Poland none Disclosure Look into the Heart
More informationHeart Failure. Subjective SOB (shortness of breath) Peripheral edema. Orthopnea (2-3 pillows) PND (paroxysmal nocturnal dyspnea)
Pharmacology I. Definitions A. Heart Failure (HF) Heart Failure Ezra Levy, Pharm.D. HF Results when one or both ventricles are unable to pump sufficient blood to meet the body s needs There are 2 types
More informationThree-dimensional Wall Motion Tracking:
Three-dimensional Wall Motion Tracking: A Novel Echocardiographic Method for the Assessment of Ventricular Volumes, Strain and Dyssynchrony Jeffrey C. Hill, BS, RDCS, FASE Jennifer L. Kane, RCS Gerard
More informationSummary/Key Points Introduction
Summary/Key Points Introduction Scope of Heart Failure (HF) o 6.5 million Americans 20 years of age have HF o 960,000 new cases of HF diagnosed annually o 5-year survival rate for HF is ~50% Classification
More informationCongestive Heart Failure Patient Profile. Patient Identity - Mr. Douglas - 72 year old man - No drugs, smokes, moderate social alcohol consumption
Congestive Heart Failure Patient Profile Patient Identity - Mr. Douglas - 72 year old man - No drugs, smokes, moderate social alcohol consumption Chief Complaint - SOB - When asked: Increasing difficulty
More informationIndications for and Prediction of Successful Responses of CRT for Patients with Heart Failure
Indications for and Prediction of Successful Responses of CRT for Patients with Heart Failure Edmund Keung, MD Clinical Chief, Cardiology Section San Francisco VAMC October 25, 2008 Presentation Outline
More informationTHE PROPER APPROACH TO DIAGNOSING HEART FAILURE WITH PRESERVED EJECTION FRACTION
THE PROPER APPROACH TO DIAGNOSING HEART FAILURE WITH PRESERVED EJECTION FRACTION James C. Fang, MD, FACC Professor and Chief Cardiovascular Division University of Utah School of Medicine Disclosures Data
More informationHeart Failure (HF) Treatment
Heart Failure (HF) Treatment Heart Failure (HF) Complex, progressive disorder. The heart is unable to pump sufficient blood to meet the needs of the body. Its cardinal symptoms are dyspnea, fatigue, and
More informationHeart Failure Background, recognition, diagnosis and management
Heart Failure Background, recognition, diagnosis and management Speaker bureau: Novartis At the conclusion of this activity, participants will be able to: Recognize signs and symptoms of heart failure
More informationHeart Failure A Team Approach Background, recognition, diagnosis and management
Heart Failure A Team Approach Background, recognition, diagnosis and management Speaker bureau: Novartis At the conclusion of this activity, participants will be able to: Recognize signs and symptoms of
More informationIncidence. 4.8 million in the United States. 400,000 new cases/year. 20 million patients with asymptomatic LV dysfunction
Heart Failure Diagnosis According to the Working Group in Heart Failure, CHF is a syndrome where the diagnosis has the following essential components: A combination of: Symptoms, typically breathlessness
More informationDiastolic Heart Failure. Edwin Tulloch-Reid MBBS FACC Consultant Cardiologist Heart Institute of the Caribbean December 2012
Diastolic Heart Failure Edwin Tulloch-Reid MBBS FACC Consultant Cardiologist Heart Institute of the Caribbean December 2012 Disclosures Have spoken for Merck, Sharpe and Dohme Sat on a physician advisory
More informationThe Role of Exercise in Management of Patients with Heart Failure
The Role of Exercise in Management of Patients with Heart Failure Pamela B. Morris, MD, FACC, FAHA, FASPC, FNLA Chair, ACC Prevention of Cardiovascular Disease Leadership Council and Section Director,
More informationEjection across stenotic aortic valve requires a systolic pressure gradient between the LV and aorta. This places a pressure load on the LV.
Valvular Heart Disease Etiology General Principles Cellular and molecular mechanism of valve damage Structural pathology Functional pathology - stenosis/regurgitation Loading conditions - pressure/volume
More informationIntroduction to Heart Failure. Mauricio Velez, M.D. Transplant Cardiologist APACVS 2018 April 5-7 Miami, FL
Introduction to Heart Failure Mauricio Velez, M.D. Transplant Cardiologist APACVS 2018 April 5-7 Miami, FL Disclosures No relevant financial relationships to disclose Objectives and Outline Define heart
More informationCardiomyopathy. Jeff Grubbe MD FACP, Chief Medical Director, Allstate Life & Retirement
Cardiomyopathy Jeff Grubbe MD FACP, Chief Medical Director, Allstate Life & Retirement Nebraska Home Office Life Underwriters Association March 20, 2018 1 Cardiomyopathy A myocardial disorder in which
More informationHeart Failure Management. Waleed AlHabeeb, MD, MHA Assistant Professor of Medicine Consultant Heart Failure Cardiologist
Heart Failure Management Waleed AlHabeeb, MD, MHA Assistant Professor of Medicine Consultant Heart Failure Cardiologist Heart failure prevalence is expected to continue to increase¹ 21 MILLION ADULTS WORLDWIDE
More informationThe ACC Heart Failure Guidelines
The ACC Heart Failure Guidelines Fakhr Alayoubi, Msc,R Ph President of SCCP Cardiology Clinical Pharmacist Assistant Professor At King Saud University King Khalid University Hospital Riyadh-KSA 2017 ACC/AHA/HFSA
More informationEstimated 5.7 million Americans with HF. 915, 000 new HF cases annually, HF incidence approaches
Heart Failure: Management of a Chronic Disease Jenny Bauerly RN, CHFN, APRN-BC Heart Failure (HF) Definition A complex clinical syndrome that can result from any structural or functional cardiac disorder
More informationCitation. What is New in the 2013 ACC/AHA HF Guideline. Dimensions in Heart and Vascular Care Penn State Heart and Vascular Institute
What is New in the 2013 ACC/AHA HF Guideline Dimensions in Heart and Vascular Care Penn State Heart and Vascular nstitute Friday October 18, 2013 Barry S. Clemson, MD Associate Professor of Medicine Penn
More informationMedical Treatment for acute Decompensated Heart Failure. Vlasis Ninios Cardiologist St. Luke s s Hospital Thessaloniki 2011
Medical Treatment for acute Decompensated Heart Failure Vlasis Ninios Cardiologist St. Luke s s Hospital Thessaloniki 2011 2010 HFSA guidelines for ADHF 2009 focused update of the 2005 American College
More informationValue of echocardiography in chronic dyspnea
Value of echocardiography in chronic dyspnea Jahrestagung Schweizerische Gesellschaft für /Schweizerische Gesellschaft für Pneumologie B. Kaufmann 16.06.2016 Chronic dyspnea Shortness of breath lasting
More informationSCOMPENSO CARDIACO: IL PUNTO DELLA RICERCA
Journal Club 19 Marzo 2010 SCOMPENSO CARDIACO: IL PUNTO DELLA RICERCA Alessandro Giordano Prevalence of heart failure by sex and age (NHANES:1999-2004) Circulation 2007 Incidence of heart failure by age
More informationHeart Failure Update. Bibiana Cujec MD May 2015
Heart Failure Update Bibiana Cujec MD May 2015 Disclosures Participation in clinical trial GUIDE IT (BNP in management of HF) Plan Review of new trials/ccs guidelines Management of heart failure: cases
More informationEjection across stenotic aortic valve requires a systolic pressure gradient between the LV and aorta. This places a pressure load on the LV.
Valvular Heart Disease General Principles Etiology Cellular and molecular mechanism of valve damage Structural pathology Functional pathology - stenosis/regurgitation Loading conditions - pressure/volume
More informationDefinition of Congestive Heart Failure
Heart Failure Definition of Congestive Heart Failure A clinical syndrome of signs & symptoms resulting from the heart s inability to supply adequate tissue perfusion. CHF Epidemiology Affects 4.7 million
More informationHEART FAILURE. Heart Failure in the US. Heart Failure (HF) 3/2/2014
HEART FAILURE Martina Frost, PA-C Desert Cardiology of Tucson Northwest Medical Center March 2014 Heart Failure in the US Prevalence - ~5 million 650,000 new cases annually 300,000 deaths annually Leading
More informationHeart Failure: Guideline-Directed Management and Therapy
Heart Failure: Guideline-Directed Management and Therapy Guideline-Directed Management and Therapy (GDMT) was developed by the American College of Cardiology and American Heart Association to define the
More informationIndex of subjects. effect on ventricular tachycardia 30 treatment with 101, 116 boosterpump 80 Brockenbrough phenomenon 55, 125
145 Index of subjects A accessory pathways 3 amiodarone 4, 5, 6, 23, 30, 97, 102 angina pectoris 4, 24, 1l0, 137, 139, 140 angulation, of cavity 73, 74 aorta aortic flow velocity 2 aortic insufficiency
More informationCongestive Heart Failure or Heart Failure
Congestive Heart Failure or Heart Failure Dr Hitesh Patel Ascot Cardiology Group Heart Failure Workshop April, 2014 Question One What is the difference between congestive heart failure and heart failure?
More informationUpdates in Congestive Heart Failure
Updates in Congestive Heart Failure GREGORY YOST, DO JOHNSTOWN CARDIOVASCULAR ASSOCIATES 1/28/2018 Disclosures Edwards speaker on Sapien3 valves (TAVR) Stages A-D and NYHA Classes I-IV Stage A: High risk
More informationExercise Prescription for Patients with CHF
Exercise Prescription for Patients with CHF LESLIE AYRES, PT, DPT Goals After viewing this presentation the physical therapist will be able to: Discuss and understand the diagnosis of CHF including: Clinical
More informationDiagnostic approach to cardiac amyloidosis: A case report
Diagnostic approach to cardiac amyloidosis: A case report Georgia Vogiatzi, MD, MSc, PhD 1 st Cardiology Department, Hippokration Hospital, Athens Medical School Disclosures I have no relevant relationships
More informationState-of-the-Art Management of Chronic Systolic Heart Failure
State-of-the-Art Management of Chronic Systolic Heart Failure Michael McCulloch, MD 17 th Annual Cardiovascular Update Intermountain Medical Center December 16, 2017 Disclosures: I have no financial disclosures
More informationNora Goldschlager, M.D. SFGH Division of Cardiology UCSF
CLASSIFICATION OF HEART FAILURE Nora Goldschlager, M.D. SFGH Division of Cardiology UCSF DISCLOSURES: NONE CLASSIFICATION C OF HEART FAILURE NYHA I IV New paradigm Stage A: Pts at high risk of developing
More informationHeart Failure with Reduced EF. Dino Recchia, MD, FACC, FHFSA
Heart Failure with Reduced EF Dino Recchia, MD, FACC, FHFSA Heart Failure HF is the end phenotype of almost all CV disorders Complex clinical syndrome resulting from any structural or functional impairment
More informationSevere Hypertension. Pre-referral considerations: 1. BP of arm and Leg 2. Ambulatory BP 3. Renal causes
Severe Hypertension *Prior to making a referral, call office or Doc Halo, to speak with a Cardiologist or APP to discuss patient and possible treatment options. Please only contact the patient's cardiologist.
More informationHeart Failure 101 The Basic Principles of Diagnosis & Management
Heart Failure 101 The Basic Principles of Diagnosis & Management Bill Tran, MD Non Invasive Cardiologist February 24, 2018 What the eye does not see and the mind does not know, does not exist. DH Lawrence
More informationSGK 2016 Session: Postgraduate Course in Heart Failure Lausanne, 15. June 2016 Heart Failure Guidelines 2016
SGK 2016 Session: Postgraduate Course in Heart Failure Lausanne, 15. June 2016 Heart Failure Guidelines 2016 Matthias Nägele, MD University Hospital Zurich Disclosures I have nothing to disclose. The new
More informationAn Update in Heart Failure
An Update in Heart Failure Dr Peter Dias Cardiologist Heartswest AHFCTS Fiona Stanley Hospital Disclosures No financial, industry, pharma disclosures I am not an endocrinologist References Heart disease
More informationHeart Failure in Women: Dr Goh Ping Ping Cardiologist Asian Heart & Vascular Centre
Heart Failure in Women: More than EF? Dr Goh Ping Ping Cardiologist Asian Heart & Vascular Centre Overview Review pathophysiology as it relates to diagnosis and management Rational approach to workup:
More informationAortic Stenosis: UPDATE Anjan Sinha, MD Krannert Institute of Cardiology
Aortic Stenosis: UPDATE 2010 Anjan Sinha, MD Krannert Institute of Cardiology None Disclosures 67-Year-Old Male Dyspnea and angina Class III heart failure No PND or orthopnea 3/6 late peak SEM Diminished
More informationGina G. Mentzer, MD Cardiologist, Heart Failure & Transplant Advanced Integrated Medicine & Surgery (AIMS) Program for Heart Failure April 18 th,
Gina G. Mentzer, MD Cardiologist, Heart Failure & Transplant Advanced Integrated Medicine & Surgery (AIMS) Program for Heart Failure April 18 th, 2015 Heart Failure (HF) Describe the natural course of
More informationMITRAL REGURGITATION REFERRAL TOOLKIT
1. Patient Case Summary Worksheets Use these checklists to help collect all necessary patient information. Initial echocardiogram MR symptoms and related conditions Patient conditions that may impact therapy
More informationThe Causes of Heart Failure
The Causes of Heart Failure Andy Birchall HFSN Right heart failure LVSD - HFREF Valve regurgitation or stenosis Dropsy CCF congestive cardiac failure Cor pulmonale Pulmonary hypertension HFPEF LVF Definitions
More informationIntravenous Inotropic Support an Overview
Intravenous Inotropic Support an Overview Shaul Atar, MD Western Galilee Medical Center, Nahariya Affiliated with the Faculty of Medicine of the Galilee, Safed, Israel INOTROPES in Acute HF (not vasopressors)
More informationACUTE HEART FAILURE in the ED. Pr. Samir Nouira Emergency Department Fattouma Bourguiba University Hospital Monastir Tunisia
ACUTE HEART FAILURE in the ED Pr. Samir Nouira Emergency Department Fattouma Bourguiba University Hospital Monastir Tunisia ACUTE HEART FAILURE 80% Acute Heart Failure Syndrome Sensitivity Specificity
More informationHeart. Severe. Failure. Congestive heart failure (CHF) is very. What you can do for your patients
Focus on CME at the University of Université Manitoba de Sherbrooke By Anne Fradet, MD, FRCP, CSPQ Severe Heart Failure What you can do for your patients The case of Mr. White Mr. White, 72, comes to your
More informationChapter 10. Learning Objectives. Learning Objectives 9/11/2012. Congestive Heart Failure
Chapter 10 Congestive Heart Failure Learning Objectives Explain concept of polypharmacy in treatment of congestive heart failure Explain function of diuretics Learning Objectives Discuss drugs used for
More informationThe Management of Heart Failure after Biventricular Pacing
The Management of Heart Failure after Biventricular Pacing Juan M. Aranda, Jr., MD University of Florida College of Medicine, Division of Cardiovascular Medicine, Gainesville, Florida Approximately 271,000
More informationChronic. Outline. Congestive^ Heart Failure: Update on Effective Monitoring and Treatment. Heart Failure Epidemiology. Michael G.
Chronic Congestive^ Heart Failure: Update on Effective Monitoring and Treatment Michael G. Shlipak, MD, MPH Professor of Medicine, UCSF Chief, Division of General Internal Medicine, SFVA Medical Center
More informationHeart Failure in Women
Heart Failure in Women Disclosure Professor Sindone has received honoraria, speaker fees, consultancy fees, is a member of advisory boards or has appeared on expert panels for: Professor Andrew Sindone
More informationHeart Failure CTSHP Fall Seminar
Heart Failure CTSHP Fall Seminar Laurajo Ryan, PharmD, MSc, BCPS, CDE Pharmacist Learning Objectives Outline the pathophysiology of heart failure List triggers for decompensated heart failure Describe
More informationUPDATES IN MANAGEMENT OF HF
UPDATES IN MANAGEMENT OF HF Jennifer R Brown MD, MS Heart Failure Specialist Medstar Cardiology Associates DC ACP Meeting Fall 2017 Disclosures: speaker bureau for novartis speaker bureau for actelion
More informationFattori condizionanti la sopravvivenza nel paziente con scompenso di cuore
Journal Club 13 Febbraio 2008 Fattori condizionanti la sopravvivenza nel paziente con scompenso di cuore Intissar Sleiman Prevalence of heart failure by sex and age (NHANES:1999-2004) Circulation 2007
More information5 Important Things to Know About Heart Failure. Kia Afshar, MD
5 Important Things to Know About Heart Failure Kia Afshar, MD Disclosures I have no conflicts of interest to disclose I will not be discussing any off label medications and/or devices Objectives 1) Understand
More informationNCAP NATIONAL CARDIAC AUDIT PROGR AMME NATIONAL HEART FAILURE AUDIT 2016/17 SUMMARY REPORT
NCAP NATIONAL CARDIAC AUDIT PROGR AMME NATIONAL HEART FAILURE AUDIT 2016/17 SUMMARY REPORT CONTENTS PATIENTS ADMITTED WITH HEART FAILURE...4 Demographics... 4 Trends in Symptoms... 4 Causes and Comorbidities
More informationThe role of remote monitoring in preventing readmissions after acute heart failure
The role of remote monitoring in preventing readmissions after acute heart failure October 20, 2017 Randall C Starling MD MPH FACC FAHA FESA FHFSA Professor of Medicine Kaufman Center for Heart Failure
More informationMedical Policy and and and and
ARBenefits Approval: 10/12/2011 Effective Date: 01/01/2012 Revision Date: Code(s): 93799, Unlisted cardiovascular service or procedure Medical Policy Title: Percutaneous Transluminal Septal Myocardial
More informationHEART FAILURE. Study day November 2018 Sarah Briggs
HEART FAILURE Study day November 2018 Sarah Briggs Overview and Introduction This course is an introduction and overview of heart failure. Normal heart function and basic pathophysiology of heart failure
More informationHeart Failure A Disease for the Internist?
Heart Failure A Disease for the Internist? Dr Chris Davidson Sussex Cardiac Centre BRIGHTON UK Hot Topics in Heart Failure Drug treatments Valsartan / neprilysin inhib Investigations BNP and others Devices
More informationHeart Failure Syndromes related to Unusual Cardiomyopathies
Heart Failure Syndromes related to Unusual Cardiomyopathies Juan M. Aranda Jr., M.D. Professor of Medicine Medical Director of Heart Failure/ Transplant Program University of Florida College of Medicine
More informationCor pulmonale. Dr hamid reza javadi
1 Cor pulmonale Dr hamid reza javadi 2 Definition Cor pulmonale ;pulmonary heart disease; is defined as dilation and hypertrophy of the right ventricle (RV) in response to diseases of the pulmonary vasculature
More informationESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Patients t with acute heart failure frequently develop chronic heart failure Patients with chronic heart failure frequently decompensate acutely ESC Guidelines for the Diagnosis and A clinical response
More informationCASE DISCUSSION. Dr JAYASREE VEERABOINA 2nd yr PG MS OBG
CASE DISCUSSION Dr JAYASREE VEERABOINA 2nd yr PG MS OBG Normal Cardiovascular changes in Pregnancy CARDIAC OUTPUT 5 th wk -- starts 12 wks -- 30-35% 30-32 wks -- 40% During labour -- 50% After delivery
More informationDISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.
DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this
More informationHeart Failure Update John Coyle, M.D.
Heart Failure Update 2011 John Coyle, M.D. Causes of Heart Failure Anderson,B.Am Heart J 1993;126:632-40 It It is now well-established that at least one-half of the patients presenting with symptoms and
More information